Bioequivalence Study for Lamotrigine Tablets 200 mg Under Fed Condition

NCT01513681 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Lamotrigine
DRUG: Lamictal®

Sponsor

Dr. Reddy's Laboratories Limited